About this trial
This multicenter study aims to establish the normal reference range of the Right Atrioventricular Coupling Index (RACI) in healthy Chinese adults using AI-based 3DE technology. It will also analyze the correlation between RACI and physiological parameters such as age, gender, and body surface area. Additionally, the study will explore the variation characteristics of RACI in patients with pulmonary hypertension, heart failure, tricuspid regurgitation, and atrial septal defect, and evaluate the clinical value of RACI in disease diagnosis, differential diagnosis, and risk stratification.
Eligibility criteria
Qualifiers
Of Han Chinese ethnicity
Aged 18-79 years
Normal blood pressure (< 140/90 mmHg)
Normal fasting blood glucose
Disqualifiers
Clinically significant cardiac valve regurgitation (≥ mild severity)
Respiratory diseases: acute or chronic respiratory disorders
Endocrine diseases: thyroid disease, diabetes mellitus, hyperaldosteronism, pheochromocytoma, etc.
Abnormal liver function (alanine transaminase > 2× upper limit of normal), abnormal renal function (elevated creatinine beyond normal range), or dyslipidemia (elevated triglycerides, total cholesterol, low-density lipoprotein, or high-density lipoprotein)
Trial design
Treatments tested in this trial
- Not listed